Autor: |
Elias, Darcielle Bruna Dias, Barbosa, Maritza Cavalcante, Rocha, Lilianne Brito da Silva, Dutra, Luana Letícia Alves, Silva, Herivaldo Ferreira da, Martins, Alice Maria Costa, Gonçalves, Romélia Pinheiro |
Předmět: |
|
Zdroj: |
British Journal of Haematology; Feb2013, Vol. 160 Issue 3, p410-412, 3p, 1 Chart, 1 Graph |
Abstrakt: |
The article discusses the evaluation of a therapeutic proposal of using L-arginine as an adjuvant drug with the Hydroxycarbamide (HC) for the treatment of sickle cell anemia (SCA). It further presents that the characteristic features of SCA is the homozygosity of Haemoglobin S (HbSS), vaso-occlusion and chronic haemolysis. It also mentions that HC works by increasing the synthesis of haemoglobin and by reducing haemolysis. |
Databáze: |
Complementary Index |
Externí odkaz: |
|